Johnson & Johnson Weighs $20 Billion Sale of Its Orthopedics Unit to Apollo
J&J is in talks to sell DePuy Synthes, its $9.3B hip-and-knee unit, to Apollo for about $20B. A deal could close in weeks—or J&J may spin it off.
J&J is in talks to sell DePuy Synthes, its $9.3B hip-and-knee unit, to Apollo for about $20B. A deal could close in weeks—or J&J may spin it off.
Blue Owl saw redemption requests fall in Q2, with its flagship fund dropping to 19% from 22%. Total withdrawals eased to $4.7 billion amid improving investor confidence.
Private equity funds face heavy withdrawals, causing limits and stock drops as investors worry about liquidity and valuations.
Apollo is buying Emerald and Questex to build a big live-events platform with 160 B2B shows across North America by 2026.
Apollo Global and Blackstone are in talks to provide Broadcom with up to $35 billion in private credit to fuel its AI chip development and production.
Apollo Global limits withdrawals to 5% in Apollo Debt Solutions after 11.2% redemption requests hit private credit funds amid investor anxiety.